Speaking on the sidelines of the International Conference on Venomous Animals and Antivenom, Dr. Moradi Bidhendi highlighted the significance of the conference, which coincides with the centenary of the institute's establishment and its prominent role in vaccine and therapeutic serum research and production in the country. The conference is held with the support of the WHO and featured contributions from six internationally recognized researchers alongside distinguished Iranian scholars.

Dr. Moradi Bidhendi noted the primary goal of the event is to present the latest research findings through keynote speeches and foster international collaboration aimed at protecting human lives from snake and scorpion bites.

She also emphasized the institute's ongoing international collaborations, which include organizing training courses and seminars in biological products, such as FMD course in collaboration with the FAO, as well as international programs for African and Central Asian countries focused on biological product production.

In recent years, Razi Institute has successfully exported and transferred the technology for producing therapeutic serums to various countries, including Iraq. Dr. Moradi Bidhendi pointed out that, given the institute's experience with reference and international laboratories, such as the WOAH reference laboratory for goat and sheep pox, it is taking necessary steps to obtain the relevant licenses for a WHO collaborating laboratory in the field of venom and antivenom.

She stated that the goal of all research and conferences is to improve strategies for safeguarding human health, emphasizing the institute's national and transnational vision. She expressed hope that Razi Institute's international activities will continue to expand significantly.